Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.

Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer ...

SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, ...

By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...